Clinical Trial Update: Identifying Effective and Cost-Conscious Maintenance Daratumumab Dosing [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update aims to identify an effective and cost-conscious maintenance dosing regimen for daratumumab in patients with multiple myeloma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Daratumumab (Darzalex) (daratumumab)

Snippet

Sponsor: Eden Biltibo | Conditions: Multiple Myeloma | Phase 2 | Status: NOT_YET_RECRUITING